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o n t h e c o v e r Science and architecture are moving away from the
era in which a laboratory was built
to order for a single scientist. New
buildings and renovations to older
ones aim to provide more support
space for scientists, as well as more
flexibility. Modern lab buildings
include a little wiggle room, including common areas that encourage
mingling among scientists.
Illustration by Shane McGowan
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I was very pleased to see the
Yale Physician Associate Program
featured in the Autumn 2009
issue of Yale Medicine [“Yale’s
Physician Associate Program
Nears 40”], and to read the history of how the program came
to be and how it has successfully evolved since 1970. Several
points deserve emphasis. While
the Duke program preceded the
founding of ours by five years, it
focused heavily on returning U.S.
military corpsmen, which was
not the emphasis of the Yale program, even from the beginning.
The Yale program drew its applicants from a broad spectrum of
individuals who had health care
experience and were committed
to working in some aspect of primary care. Although the program
was born out of the trauma program under the Department of
Surgery chaired by Jack W. Cole,
m.d., all students received generalist training across the medical
landscape and were prepared to
enter any field of medicine. From
the beginning, the faculty and
leadership of the entire Medical
School were very supportive.
The program leadership,
including Blair L. Sadler, j.d., Ann
A. Bliss, r.n., and Paul Moson,
pa-c, was committed to a program that was open equally
to women and men. Although
the first classes had more men
than women, the applicant pool
quickly evolved to the point that
there were more women than
men. Recent classes have more
than 70 percent women, which
corresponds to the national
average. The white paper on the
future of the physicians’ assistants, prepared for five national
foundations by Sadler, Sadler, and
Bliss in 1971, drew the blueprint
for the evolution of the field
and served as the basis of the
first policy book on pas that is
still used in programs today, The
Physician’s Assistant—Today and
Tomorrow (Yale University Press,
1972). The Yale pa Program continues to provide national leadership through its faculty directed
by Mary Warner, pa-c, and by its

accomplished graduates, who
now number more than 900.
Congratulations to Yale
School of Medicine for embracing a bold experiment in medical
education that enhanced its
development and provided leadership for the field nationally.

Alfred M. Sadler Jr., m.d.
Founding Director, Yale pa Program

Strong forces aligned
against medicine

“Doctors for America,” which
appeared in the Winter 2010 issue
of Yale Medicine, emphasized
the need for physicians to be
engaged in health reform.
Never have the forces aligned
against medicine been so numerous and so strong. The destiny of
the profession has been jerked
out of physicians’ hands by insurance and drug companies. Their
profit-based goals undermine
medicine’s humanism. Thus
Doctors for America’s efforts to
recruit physicians to protect the
heart and soul of medicine are as
necessary as they are admirable.
Two issues resonated strongly
with me: increasing the reimbursements for primary care physicians and eliminating the defects
of the malpractice system.
As is widely known, most
students are turned off by primary care. But merely paying
these physicians more for their
services is not the whole answer.
Their training should be more in
touch with what the real world
requires of them. In my pre-med
years I knew several students
who would have made excellent
general practitioners but who,
because of average grades in
organic chemistry or biochemistry, lost out on their dreams of
becoming physicians.
Making the basic science
courses less intensive for those
interested in primary care would
attract more into the specialty.
This sounds heretical, but most
primary care doctors have no
need for the organic chemistry
and physics and biochemistry that
they endured as rites of passage.
The biggest problem with
the malpractice system is that
it allows unpreventable bad

outcomes to be misconstrued as
malpractice. Because malpractice
suits can seriously harm physicians’ reputations and livelihoods,
many doctors order tests and
consultations that are not necessary specifically to ward them off.
Not only does this raise the cost
of health care immensely but it
exposes patients to risky procedures and medications.
One thing is certain: Without
strong physician engagement, the
destiny of the medical profession
will remain in the hands of those
whose methods and goals undermine the humanitarian impulses
that attracted most doctors to
medicine in the first place.
Edward J. Volpintesta, m.d.
Bethel, Conn.

No guarantee of
happiness in life

The article in the Winter 2010
issue [“Doctors for America”]
floored me with its naïve egalitarian comments, especially from
young physicians. The commentators bemoaned inequality in
health care access and that health
care is not a right, and argued
for the need for comprehensive
services—including that sticky
marshmallow, mental health.
Theoretically there may be
equality of opportunity, even fairness under law, but emphatically
people are not clones. We are not
all tall, blond, and blue-eyed; I certainly am not (just informed, realistic, and elegant, which is enough).
We are not guaranteed certified Grade A parents. So far the
government does not send a nice
cake and a sunny day on your birthday. There never will be enough
Château Palmer for everyone.
People are much different in
abilities and fortunes. There may
be a right to pursue happiness, but
there is no guarantee thereof. The
good die young and I am retired.

Eugene Patrick Cassidy, m.d. ’66
Marshalltown, Iowa

starting point
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Alumni offer their time and wisdom
In February about a dozen alumni, as well as past and current faculty members, came together at
New Haven’s Lawn Club for the inaugural meeting of Yale Medicine’s advisory board. The group
spanned the decades and created some interesting juxtapositions as former students engaged
their former teachers in a new forum. (One alumna later commented that it was the first time
she’d seen the face of a surgeon who’d been her teacher—as a student she’d seen only his eyes
peering out from above his mask in the operating room.)
The group owes its existence to our readers’ survey, which we completed last year.
The feedback from the survey was resoundingly positive; we thought an advisory board would
allow us to extend and maintain our links to our readership. We asked about 15 alumni and faculty members to gather twice a year to tell us what they like about Yale Medicine, what they think
could be better, and what they’d like to see in its pages. We also asked the members—several of
whom are authors and whose numbers include a nationally recognized writer/physician, a leading cardiothoracic surgeon, and a former deputy dean—to serve as a sounding board and offer
their advice in their respective areas of expertise.
At this first meeting the conversation continued more than half an hour past our allotted
time; it was another half hour before everyone left. Members of the new advisory board
bombarded us with topics and ideas for future articles in Yale Medicine. We hope to see many of
these ideas in the pages of the magazine or in our Online Extra edition. Thanks to all the board
members who offered their time, expertise, and wisdom.
John Curtis
Managing Editor
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chronicle news from cedar street
cloudy formaldehyde, their gray matter
crumbling at the edges. Since the
mid-1990s and continuing to this day,
students paid their respects by signing
a poster in the room, thereby becoming
members of the “Brain Society.”
“The pledge on the poster was ‘Take
Only Memories,’ ” said Terry Dagradi,
a photographer at the medical school
who has been working on the preservation and cataloging of the collection’s
archive of patient photographs.
The brains belonged to patients of
Harvey Cushing, m.d., the pioneering
neurosurgeon, who preserved them as
part of his tumor registry and left them
to Yale upon his death in 1939. In storage since the 1950s, they are about to
come to light again. During the 1990s
Christopher Wahl, m.d. ’96, wrote
his thesis on the collection, bringing
new attention to the Cushing brains.
Now, under the direction of Dennis D.
Spencer, m.d., hs ’76, chair and
Harvey and Kate Cushing Professor of
Neurosurgery, the collection is being
restored and moved to a “brain library”
within the medical library. The Cushing
Center, designed by architect Turner
Brooks, will display all 550 brains in
jars. Some will be shown alongside
Cushing’s meticulous medical records
and striking photographs of patients.
“I don’t know of another library that
has a collection of autopsied preserved
brains as their primary holdings,”
said Spencer.
When he began the project in 2005,
much of the brains’ formaldehyde had
partly evaporated long ago, and what

Cushing collection once
again open for research
Library makes a new home for
the tumor registry while an autopsy
vindicates the neurosurgeon.

t o p Pioneering neurosurgeon Harvey Cushing’s tumor registry included detailed records
of each patient, photographs of the patients,
brains, and tumor samples. The collection, which
had been stored in a basement room under the
Harkness dormitory, is moving to a new home—
the Cushing Center in the Cushing/Whitney
Medical/Historical Library.
t er r y d a gr a d i (2 )
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Over the years, in what became a rite of
passage, Yale students would break in—
by unscrewing a door panel and squeezing inside—to a room in the basement
of Harkness Dormitory. It is a daunting
trek, dimly lit, beneath oversized heating and ventilation ducts and through
spaces that haven’t seen a broom or
mop in years. The students came to see
the brains. Hundreds were lined up
on dusty metal shelves, submerged in

l e f t Dennis Spencer, chair of neurosurgery,
holds a specimen in the basement where the
Cushing tumor registry has been stored. Spencer
has been leading the restoration of the collection.
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remained was dirty. The jars had leaky
seals and were coated in filth. Nicole
St. Pierre, who holds a degree in forensic science and will soon begin training
as a physician associate, is cleaning
them and replacing the preservative.
Dagradi and others will coordinate
the displays. The Cushing Center will
open on June 5, with Kate Cushing,
Harvey Cushing’s granddaughter, taking part in the ribbon cutting.
Perhaps the most famous brain in
the collection belonged to a well-known
figure of the early 1900s: Major General
Leonard Wood, m.d. A physician and
friend of Theodore Roosevelt, he led
the Rough Riders’ charge up San Juan
Hill, and was governor of Cuba and the
Philippines. In 1904, in his 40s, Wood
suffered seizures in his left leg. For a
time, he treated them by sniffing chloroform. But after a few years the seizures
and a growing lump on his skull could
no longer be ignored. Cushing agreed
to operate, though no one at the time
had much experience in removing brain
tumors. In a groundbreaking 1910 operation at Johns Hopkins, Cushing removed
a large benign growth; it proved to be a
meningioma, a tumor of the lining of
the brain. Wood was cured of his seizures and resumed his active life, which
included service as Army chief of staff
and a candidacy for the Republican presidential nomination in 1920.
The success of the operation so
impressed a group of Harvard physicians that they invited Cushing to
relocate to the brand-new Peter Bent
Brigham Hospital in Boston. He
agreed and went on to become the
father of neurosurgery.
But Wood’s tumor recurred, forcing him to return from the Philippines
in 1927. Cushing, by now far more
experienced, operated again, and found
a second meningioma almost twice
the size of the first. After a difficult
operation and much blood loss it was
removed and the patient appeared to be
recovering. A few hours later, though,
Wood became unresponsive and died.
Cushing autopsied him and found the

ventricles of the brain filled with blood.
Devastated, he preserved both brain and
tumor and wrote up the case in his
1938 textbook, Meningiomas, which he
co-authored with neuropathologist
Louise Eisenhardt, m.d. With customary precision and candor, he blamed
himself for failures of surgical judgment. He retired five years later.
“It’s amazing how these two men’s
careers were so much in parallel,” said
Spencer. “They crossed at the beginning
of their careers and again at the end.”
Spencer and St. Pierre recently reautopsied Wood’s brain to learn more
about his death; Spencer had suspected
that a bleeding vessel from the tumor
was the culprit. But he could find none,
and he now thinks the primitive blood
transfusion practices of the day may
have disturbed Wood’s clotting mechanisms and led to the deadly bleed.
It was postmortem examinations like
these that made the Cushing brains such
an important resource. Before imaging
technology was available, surgeons and
pathologists studied gross specimens to
see damage wrought by strokes, tumors,
or injuries. But few brains are saved
today, since autopsies are falling out of
favor—CT and mri are the preferred
teaching tools. Yet even though they’re
not used for didactic purposes, said
Spencer, the brains are “beautiful and
historic.” And as the students knew, they
make an impressive sight. Alongside
Cushing’s detailed writings and photographs, they embody memories of neurosurgery’s pioneering era.
—Jenny Blair

Online: Yale Netcasts
Dennis Spencer: Doctors Develop Surgical Cure
for Epilepsy by Watching the Brain at Work

et cetera • • •
W E B S I T E T R AC K S A R R A F U N D I N G

Since February 2009 Yale faculty have received
more than 280 research awards with a value
of $121 million through the American Recovery
and Reinvestment Act (arra). The act’s goal
is to reinvigorate the economy and stimulate
long-term growth through increased investments in infrastructure, education, the environment, and scientific research.
The university in January debuted a website designed to provide information about
grants received through arra. The website,
opa.yale.edu/sp/arra1/, includes vignettes
of faculty research, background information on the competitive process used to select
applications, and such key statistics as the
number of jobs created or retained through
arra-funded projects. The site also links to a
site developed by the Association of American
Universities, the Association of Public and
Land Grant Universities, and the Science
Coalition. That site demonstrates the impact
of arra funding at research universities
across the country.
—John Curtis
YA L E D O C S O N H A I T I M I S S I O N

Six health professionals from the School
of Medicine and Yale-New Haven Hospital
treated about 400 victims of the Jan. 12
earthquake at a hospital in the town of
Hinche in February.
“We were careful to make sure that we
took the right people with the right stuff to
the right place,” said Gregory Luke Larkin, m.d.,
professor of emergency medicine. Although
the earthquake struck Port-au-Prince, many
patients are being sent to other sites for
medical treatment.
The team brought $12,000 worth of equipment and supplies, as well as their own food
and water. “We didn’t need to drain any of the
local resources,” said Larkin.
The group treated fractures and crush injuries, many of which were worsened by delays
in obtaining medical care. Wounds that would
have been minor if treated early became
infected, often requiring amputation.
Medical teams continue to arrive in Haiti
to relieve one another. “We handed off the
baton,” said Larkin, “but the road to recovery
is a long one.”
—Jill Max
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A video game to help teens
make the right choices about
preventing hiv
For many teenagers, the high point
of an interactive video game is being
as bad as they can be—crashing the
most vehicles or squashing the most
opponents. Between them, Lynn E.
(Sullivan) Fiellin, m.d. ’96, hs ’00, and
David A. Fiellin, m.d., hs ’95, have five
children ranging in age from 11 to 20,
and as Lynn Fiellin watched them play
their video games she realized that she
could tweak that concept. She envisioned an interactive game in which
kids score points not by pulverizing
opponents but by making choices that
could help them reduce risk behaviors
and avoid hiv infection.
This year the Eunice Kennedy Shriver
National Institute of Child Health and
Human Development gave the School
of Medicine a five-year research grant
to develop and test such a game. Fiellin,
assistant professor of medicine, has
gathered a team of like-minded experts,
including her husband, an associate
professor of medicine and an addiction
researcher, and other Yale faculty. Fiellin
is working with such experts as Alexander Seropian, executive producer of
the popular Halo science fiction video
game, on game design and development.
Ben Sawyer, co-founder of the Games for
Health Project, funded by the Pioneer
Portfolio of the Robert Wood Johnson
Foundation, is assisting as a consultant
working with other game designers.
“Harnessing technology for health
behavior games is a vastly growing area,”
said Fiellin, an attending physician in
Yale’s Primary Care Center and Nathan
Smith hiv Clinic.

The game is still in its earliest stages
of development, but Fiellin envisions
an interactive world in which the player,
using an avatar (virtual character),
“travels” through life, making decisions
that bring different risks and benefits.
The players will be able to see how their
choices affect their lives and can move
back in time to see how different actions
might lead to different outcomes. By negotiating challenges in a highly repetitive
and meaningful way, the player should
learn skills that equip him or her to avoid
real-life situations that increase their risk
of hiv. “Through the video game play we
can evaluate in real-time how our players
are acquiring skills to help them make
better choices,” Fiellin said.
She plans to conduct a randomized
clinical trial with 330 ethnically diverse
children between 11 and 14 years old at
an after-school program in a New Haven
community center in order to study the
game’s impact on delaying the age of
initial sexual activity. She expects eventually to distribute the game to schools

throughout the country, although teenagers can also play it at home, on cell
phones, or on personal digital assistants.
The game has international implications,
as access to the Internet is on the rise in
developing countries that have growing
hiv epidemics but only limited access to
targeted risk-reduction strategies.
In 2006, more hiv infections occurred in individuals between the ages of
13 and 29 than in any other age group in
the United States, according to the most
recent figures available from the Centers
for Disease Control and Prevention. “If
we start teaching kids about risky behaviors early,” Fiellin said, “maybe we can
prevent some cases of hiv.”
—Kathy Katella
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“Amazing” rnas found
to play a more complex role
than thought
Any biology textbook will depict proteins as the workhorses that carry out
the lion’s share of biochemical reactions
in cells. Aside from a few exceptions,
however, rnas have largely been pigeonholed as passive middlemen between
dna and proteins.
New findings from the laboratory of
Ronald Breaker, ph.d., Henry Ford II
Professor of Molecular, Cellular, and
Developmental Biology, and Howard
Hughes Medical Institute Investigator,
suggest that rnas play a more complex
role than previously thought, and that,
in certain tasks in certain organisms,

10 Nucleotides

z a s h a w ein b er g ( 2 )

A typical rna molecule (above) involved in
transfer of genetic information is dwarfed by the
rna molecule golld (below), the third-largest
and most complex rna discovered to date. golld
appears to be used by viruses that infect bacteria.

they take on a more dominant role
than proteins. Breaker and colleagues
have discovered a slew of large rnas
that do not code for proteins but instead form complex three-dimensional
structures in simple organisms like
bacteria—structures that may carry out
complex biochemical functions. “Every
time we feel as though we’re giving rna
just about the right amount of credit, we
find more amazing rnas,” said Breaker.
“I think this is just a continuation
of the data that forces us to move our

standards ever higher for what we think
rna should be able to do.”
First author Zasha Weinberg, ph.d.,
a postdoc in Breaker’s lab, and colleagues
reported in the December 3 issue of
Nature on several new large noncoding rnas in bacteria, two of which the
research team christened golld and
hearo. Preliminary work suggests that
golld helps viruses that infect bacteria
to burst out of infected cells so that they
can seek new targets, whereas hearo
might be a mobile genetic element,
which are present in all organisms and
a cause of spontaneous genetic change.
Breaker’s group culled these and
other noncoding rnas out of stretches
of “junk dna” that do not code for
proteins. The researchers matched junk
dna sequences between related bacteria
to identify stretches that were highly conserved—a red flag that signals evolutionary preservation and perhaps importance.
They then looked at these conserved dna
sequences to pick out regions that, when
transcribed into rna, could form complex rna structures—hairpins, loops,
and knots—enabling them to sift out
the probable noncoding rnas.
Breaker hasn’t determined whether
these noncoding rnas represent living
relics of an ancient rna-centered world
that might have existed before proteins
evolved and drove many catalytic rnas
to extinction, or whether they represent
more modern developments.
Whatever their origin, given the
number of noncoding rnas that Breaker
suspects may be active in select organisms, he feels it is important to come
to grips with how modern cells really
function. “It’s not that the science that
we know about modern cells is wrong,
but as we find more and more noncoding rnas, we recognize how incomplete
our understanding is,” Breaker said.
—Kara A. Nyberg

Online: Yale Netcasts
Ronald Breaker:
Riboswitches: Nature’s Ancient Turn-On

et cetera • • •
M E D I C A L E X P E R T S for media

Yale Medical Group (ymg) in December launched
a website that offers access to 90 specialists in
clinical care and scientific research to journalists on deadline. The scientists on this website
represent some of the nearly 800 members
of ymg who treat patients, teach, and conduct
research at Yale.
The website, opa.yale.edu/experts, can
also be accessed through the Office of Public
Affairs, opa.yale.edu, by clicking on the link
“For The Media: Find a Medical Expert.”
The site contains more than 50 categories
of experts, with photos, profiles, and video
clips of the experts and a link to their contact
information. Instructions are also available
for setting up remote television or radio interviews with the Yale experts. (Yale University
maintains a professional radio and television
broadcast studio in New Haven with full satellite transmission capability.)
—John Curtis
N A N O S E N S O R S T E ST F O R C A N C E R

Yale researchers have for the first time used
nanosensors to measure two cancer biomarkers in whole blood, opening up the possibility
of simpler testing for cancer and other diseases.
“Nanosensors have been around for the
past decade, but they only worked in controlled laboratory settings,” said Mark A. Reed,
ph.d., the Harold Hodgkinson Professor of
Engineering and Applied Science and Electrical
Engineering. “This is the first time we’ve been
able to use them with whole blood, which is
a complicated solution containing proteins,
ions, and other things that affect detection.”
Reed and Tarek Fahmy, ph.d., associate professor of biomedical and chemical
engineering, reported on December 13 in
the advance online publication of Nature
Nanotechnology that they had developed
a device that can detect concentrations
equivalent to a grain of salt in a swimming
pool. The device can detect biomarker concentrations in minutes instead of days and
could test for a wide range of biomarkers for
disorders from ovarian cancer to cardiovascular disease.
—J.C.
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Getting the science on paper
A new guide helps scientists avoid basic writing mistakes
and express their ideas clearly.

stop” reference guide
d communication

S

riting mechanics as word choice and word location,
ving into manuscript planning and organizational
ntific documents and presentations then follows.

om real research papers and grant proposals by
ear technical writing as well as common mistakes
range of scientific disciplines including medicine,
y, engineering, and physics.

pportunity to review style and composition priniting.

entists against common pitfalls and equip them
aper, review article, or grant proposal.

d guidelines to life by applying them to real-world,

to both native and non-native English speakers;
e English speakers.

o write successful grant applications and how to

to master, Scientific Writing and Communication:
e of readers—from upper-level undergraduates
professional researchers—in the life sciences,

ISBN 978-0-19-539005-6
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niversity.

Scientific Writing and Communication

nd Presentations covers all the areas of scientific
to successfully promote his or her research and
ussion of the basics of scientific writing style and
search papers, review articles, grant proposals,
ademic presentations and posters.

Hofmann

Angelika H. Hofmann, ph.d., conducted a modest study before
beginning her book on scientific writing. To gauge the state of
the art, Hofmann examined 100 prepublication drafts of scientific papers. She found pervasive problems: unnecessary repetition, over-long sentences, missing information, and faulty verb
tenses. Three out of four authors had misplaced or omitted such
an essential element of the paper as
Angelika H. Hofmann
the purpose of the experiment.
Hofmann’s new book, Scientific
Writing and Communication, provides a broad-spectrum remedy
Scientific Writing
and Communication
for such ills. In 700 pages, she
offers step-by-step instructions for
producing research papers, review
articles, grant proposals, posters,
talks, and job applications.
Ë|xHSKBTFy390 56zv*:+:!:+:! 4 3
Hofmann, a writer and grant
editor at Yale’s Office of DevelopScientific Writing
and Communication:
ment and an adjunct instructor
Papers, Proposals,
who teaches Scientific Writing I,
and Presentations
begins with such fundamental
By Angelika H. Hofmann,
principles of composition as keepph.d., writer and grant
ing tenses straight and sentences
editor for corporate and
foundation relations, Yale
short. She addresses such topics
Office of Development
as using references, avoiding
(Oxford University Press)
plagiarism, overcoming writer’s
block, and choosing between figures and tables to report data.
Summary boxes and revision checklists consolidate information. The book includes samples of both good and bad writing,
alongside suggested revisions for the clunkers.
Hofmann estimates that about half of scientists writing in
English are not native speakers; throughout, she includes notes
addressing such writers. Each chapter ends with exercises,
and answers appear in the back of the book.
As Hofmann points out, the scientific enterprise requires
not only running sound experiments but also disseminating
results. Skillful communication, she writes, “is the engine that
propels virtually all scientific progress.”
—Cathy Shufro
PA P e r s, ProPosAls, and P r e s e n tAt i o n s

Blows to the Head: How
Boxing Changed My Mind
by Binnie Klein, m.s.w., lecturer in
psychiatry (State University of New
York Press) The author offers a
series of memories and insights
from an unlikely contender. Klein’s
unexpected midlife fascination
with boxing takes her beyond the
ring, leading her back to her roots
and to a surprising chapter of
the Jewish immigrant experience.
Klein shows us that if we turn over
the “weird stones” on our path—
the ones we usually ignore—we
may find ourselves on a remarkable and revitalizing journey.

Acute Pain Management
by Raymond S. Sinatra, m.d.,
ph.d., professor of anesthesiology;
Oscar A. DeLeon-Cassasola, m.d.;
Eugene Viscusi, m.d.; and Brian
Ginsberg, m.d. (Cambridge University Press) This textbook provides a comprehensive overview of
acute pain management, including
the anatomy of pain pathways;
the pathophysiology of severe
pain; pain assessment; therapeutic
guidelines and analgesic options;
organization of pain services; and
the roles of anesthesiologists,
surgeons, pharmacists, and nurses
in providing optimal care.

Human-Animal Medicine:
Clinical Approaches to Zoonoses,
Toxicants and Other Shared
Health Risks
by Peter M. Rabinowitz, m.d.,
m.p.h., associate professor of medicine; and Lisa A. Conti, d.v.m.,
m.p.h. (Saunders) This reference
work explores the convergence
of human, animal, and environmental health concerns. It calls
for greater communication and
cooperation among human health
care providers, public health professionals, and veterinarians to
address vital issues of emerging
diseases and environmental
change. This book provides practical guidelines for collaborations
on a wide range of clinical humananimal health issues, including
the H1N1 virus, zoonotic diseases,
the human-animal bond, animal
allergy, bites and stings, and
animals as sentinels of environmental health hazards.

Pathology of the Breast
by Fattaneh A. Tavassoli, m.d.,
professor of pathology (McGrawHill Companies) This book
provides information on all
benign and malignant lesions of
the breast. It focuses on facts and
details that pathologists need to
make precise critical diagnoses:
morphological features, differential diagnoses, and diagnostic aids
for both common and rare lesions
in men as well as in women.
The book includes illustrations,
photographs, photomicrographs,
and extensive literature reviews.
Speech Sound Disorders
in Children: In Honor
of Lawrence D. Shriberg
edited by Rhea Paul, ph.d.,
ccc-slp, lecturer in the Child
Study Center; and Peter Flipsen Jr.,
ph.d. (Plural Publishing) This text
provides insights from a variety
of perspectives and disciplines
into the development of children’s
speech sounds. The authors discuss the difficulties in the analysis
of and treatment implications for
both specific speech disorders
and the speech of children with
other primary disabilities.

on campus

Letters to a Best Friend
by Richard Selzer, m.d., hs ’61;
Peter Josyph, editor (suny Press)
This book is the record of two
decades of written conversation
between two friends: Selzer, the
essayist, short story writer, and
former surgeon; and Peter Josyph,
a New York painter, actor, and
filmmaker who began the correspondence in 1988. The book is an
edited selection of the thousands
of letters that Selzer wrote about
his life, his work, and his friendship with Josyph.
The Treatment of Eating
Disorders: A Clinical Handbook
by Carlos M. Grilo, ph.d., professor of psychiatry and psychology;
and James E. Mitchell, m.d.
(The Guilford Press) This clinical
handbook brings together leading
international experts on eating
disorders to describe the most
effective treatments and their
implementation. Coverage encompasses psychosocial, familybased, medical, and nutritional
therapies for anorexia nervosa,
bulimia nervosa, binge eating
disorder, and other disorders and
disturbances. The volume also
provides an overview of assessment, treatment planning, and
medical management issues.
Special topics include psychiatric
comorbidities, involuntary treatment, support for caregivers,
eating disorders in children, and
new directions in treatment
research and evaluation.

Health and Social Justice
by Jennifer Prah Ruger, ph.d.,
associate professor of public
health (Oxford University Press)
Societies make decisions and take
actions that profoundly affect
the distribution of health care.
Why and how should collective
choices be made and policies
implemented to address health
inequalities under conditions of
resource scarcity? How should societies conceptualize and measure
health disparities, and determine
whether they’ve been adequately
addressed? Who is responsible for
various aspects of this important
social problem? In this book Ruger
elucidates principles to guide
these decisions, the evidence that
should inform them, and the
policies necessary to build equitable and efficient health systems worldwide.
Netter’s Gastroenterology, 2nd ed.
by Martin H. Floch, m.d., clinical
professor of medicine; Neil R.
Floch, m.d.; Kris V. Kowdley, m.d.;
C.S. Pitchumoni, m.d.; James
Scolapio, m.d.; and Raul Rosenthal, m.d. (Saunders) This
text covers the field of digestive
diseases—including those related
to gastroenterology, hepatology, and nutrition. A templated
format offers a quick summary of
nearly 300 of the most commonly
encountered clinical conditions,
while the illustrations provided
by Frank H. Netter, m.d., depict
key anatomical structures and
highlight important concepts.
The descriptions above are based
on information from the publishers.

send notices of new books to
Cheryl Violante, Yale Medicine,
300 George Street, Suite 773,
New Haven, CT 06511, or via e-mail
to cheryl.violante@yale.edu
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SHARON BEGLEY

T R AC Y K I D D E R

Educating the public about
science is an uphill battle

Relying on the kindness
of strangers

Sharon Begley, science editor of
Newsweek, despairs of the challenge of educating the American
public about science. Such issues
as evolution, she said, have become so politically charged that a
rational discussion seems impossible. “No amount of excellent
journalism on evolution is likely to
make a difference,” she said. “We
can write it, but that doesn’t mean
that people will believe it.”
In a talk sponsored by the
Poynter Fellowship in November,
Begley said that there is a large
disconnect between factual
knowledge and belief. “Humankind has practiced magical thinking and has relied on instinctual
thinking and superstition much
longer than it has relied on critical
thinking,” she said.
While people accept scientific findings on noncontroversial
topics—most, for example, believe correctly that the center
of the planet is extremely hot—
the reverse is true for evolution.
About half the population, she
said, believes that humans and
dinosaurs coexisted. And only
21 percent know that dna is the
molecule of heredity.
“Knowledge is not enough to
support rational scientific thinking,” she said. “You have to want
to think rationally.”
—John Curtis

The central figure in Tracy Kidder’s
new book escaped death by
machete in his native Burundi,
beat overwhelming odds to get
an Ivy League education, and
returned to his war-torn country
to build a free clinic that treats
what the author called “stupid
illnesses,” which are often fatal
in Africa but easily treated in the
developed world.
In his book Strength in What
Remains, Kidder maintains that
the kindness of strangers shines
even in a dark world, as he told an
audience in Harkness Auditorium
during a talk co-sponsored by
Yale Cancer Center and wshu
Public Radio in November.
His book is the story of Deo,
a survivor of an ethnic massacre
who fled to New York City and
slept in Central Park until a childless couple adopted him and
paid his way through Columbia
University. Deo was mentored
by Paul Farmer, m.d., the subject of Kidder’s 2003 bestseller
Mountains Beyond Mountains.
Deo returned to Burundi and
built the clinic with the help of
strangers. The organization that
Deo founded and that sponsors
and operates this facility is called
Village Health Works.
The center has treated 28,000
patients since its opening in 2008.
It has become “an instrument
of peace,” Kidder said, because
the various tribes put aside their
“artificial” differences to realize
“our common susceptibility to
illness and injury.”
—John Dillon
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The physician’s
apprentice
In the early 19th century, aspiring physicians learned
by “reading and riding with the doctors.”
By Kerry Falvey

In March 1811, at the age of 22, Elijah
Woodward Carpenter of Brattleboro, Vt.,
signed his name to an indenture, a
contract with Cyrus Washburn, a doctor
in the nearby town of Vernon. Carpenter
agreed to serve as Washburn’s apprentice for the next two years or more and
pay him a fee of $133.33. In return Washburn would provide room and board in
his home, and would instruct Carpenter
“personally and by the use of books, in
the art & science of Anatomy, Surgery
and Physic.”
At that time only a handful of American medical schools existed, and
Carpenter’s apprenticeship represented
the most common form of medical
training in the New World. The Medical
Institution of Yale College had been
chartered the previous year, but its first
class, in which Carpenter would be one
of 37 students, would not begin studies
until November 1813.
For the elite, premier medical training could be had in European universities. But for Carpenter—who was
born in a log hut—university training
in Europe was not an option. In fact, it
took him three years to pay Washburn’s
fee. For most Americans who wished
to pursue medicine, apprenticeship to a
local practitioner was the only option.
The quality of the training, which
usually lasted for two or three years,
depended on the skills of the teacher.
Often described as “reading with the
doctors and riding with the doctors,”
apprenticeship consisted of book
study and a later phase in which the
student attended his preceptor on his
rounds—on horseback.
In exchange for his on-the-job learning, the apprentice did the “grunt work” of
the medical practitioner. Carpenter agreed
to “diligently during said term attend to
the study, and art of practicing Physic,
Surgery &c. and agreeably to the directions of the said Washburn from time to
time, prepare & Compound medicines for
his the said Washburn’s use.” Carpenter
may have been lucky: Beyond compounding medicines, apprentices often tended
the horses and cleaned the stables.

Despite its shortcomings, apprenticeship offered a crude prototype of clinical
training. It was the most practical system
available, and physicians saw apprenticeship as one way to standardize medical
training. In 1800, a committee of the
Connecticut Medical Society, seeking
to regularize physician education in the
state, recommended that candidates
wishing to practice medicine be at least
21, have a good reputation, have a college
education, and have two years of study
with a respectable physician or surgeon.
When the apprenticeship concluded,
the preceptor sent off his student with
a written certificate, much like the one
Washburn provided Carpenter in July
of 1814 after Carpenter had attended
one course of lectures at Yale’s fledgling
medical institution. (Lack of funds prevented Carpenter from taking a second
course.) Washburn began his testimony
by citing Carpenter’s “reputable family”
and “good moral character.” Then
he explained that Carpenter had “with
much industry and success devoted
three years to the theory & practice
of Physic, Surgery &c. under my immediate inspection.”
Washburn’s certificate would be
virtually worthless to anyone not familiar with his skill, thus underscoring
a major problem with apprenticeship:
its authority resided with the preceptor. What was lacking was a standard
and objective body of knowledge, and
an institution to communicate such
knowledge. As the medical school grew
in stature, it would become the locus of
science, and the medical profession in
the middle and later parts of the 19th
century would embrace both.
Carpenter went on to a successful
career as a physician and surgeon in
Vermont and was a surgeon’s mate
in the Massachusetts militia. He died
in Vermont in 1855.
This article has been adapted from a forthcoming book by Kerry Falvey celebrating the
bicentennial of the Yale School of Medicine.
The book can be preordered at a discount at
yalebooks.com/ysm200.

med i c a l hi s t o r i c a l l ib r a r y
(4)
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t o p When Elijah Carpenter completed
his studies, his instructor Cyrus Washington
sent him off with a letter of recommendation that cited his good moral character and
his success in his studies of medicine.
m i d d l e In the earliest days of the School
of Medicine, students bought tickets to
lectures. Elijah Carpenter, who began his
studies with the first group of students to
enter the school, attended a first course
of lectures but could not afford a second.
b o t t o m In 1814 the state of Vermont
issued a certificate attesting to Carpenter’s
abilities in the practice of medicine.
o p p o s i t e pag e This lithograph of
Elijah Carpenter was made from a portrait
photograph taken in early 1855, the year he
died. After his apprenticeship and studies,
Carpenter went on to a successful career as
a physician and surgeon in Vermont.

13

Biotech after the bust

Five new Yale-affiliated biotech companies started up last year, but the industry sees problems ahead.

By Charles Gershman
Illustration by Rakefet Kenaan
After the U.S. and world economies faltered in the fall of
2008, it became clear that future plans for Yale’s various activities were going to change. The signs around the country and
the world were not auspicious. On September 15, 2008, the
New York financial services firm Lehman Brothers filed for
Chapter 11 bankruptcy protection. The next day, the insurance
giant American International Group (aig) suffered a liquidity
crisis after its credit rating was downgraded. aig’s stock had
already dropped 60 percent before the market’s opening that
day. The nation’s gdp then fell at a pace not seen since the
1950s. The unemployment rate in the United States more than
doubled, from 4.9 percent at the end of 2007 to 10.2 percent
in October 2009. Outside Yale, layoffs and bankruptcies were
taking place en masse. The ensuing $700 billion bailout package softened the blow but did not prevent belt tightening in
boardrooms around the world and rising global unemployment.
Whatever immunity universities may have had to previous swings in financial markets, Yale couldn’t dodge the 2008
bullet. On December 16 Yale President Richard C. Levin gave
faculty and staff the bad news: all departments and offices at
the university must find ways to cut costs. By June 2009, Yale’s
endowment had lost 29 percent of its value, from $22.9 billion

to $16.3 billion. The air—off campus and on—was filled with
uncertainty. But in the Temple Street office of Jon Soderstrom,
ph.d., it was business as usual.
The view from Temple Street

“In terms of new deals, we haven’t seen the downturn,” says
Soderstrom, director of Yale’s Office of Cooperative Research
(ocr), which helps Yale scientists found businesses based on
promising discoveries. “Hardly a week goes by when we don’t
get venture capitalists calling up to talk to us about what new
things we have. … If you were to look at our performance last
year, and you didn’t know anything about the economic downturn, you wouldn’t have guessed it.”
Last year, for example, saw five Yale startups. One
of them, Kolltan Pharmaceuticals, launched by Joseph
Schlessinger, ph.d., chair and William H. Prusoff Professor
of Pharmacology, working in partnership with ocr, raised
more than $35 million despite lean times. “Five is actually
above our average,” Soderstrom says. “We’re [usually] in the
three-to-four range. In terms of financing, we didn’t see a
significant downtick in any of our numbers—licenses, royalties, revenue-generating technology, startups.”
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The number of new startups is not the only sign that
New Haven biotech is on the rise. Office occupancy rates in
New Haven are up, laboratory space is tight, and developers
are racing to keep up, notes John Puziss, ph.d., ocr’s director of
technology licensing. “Hopefully, with the economic crisis sort
of easing and more money being available for investing in technologies, we’ll see more startups coming out of Yale,” he said.
But the increase in the number of new deals, Soderstrom
notes, is only one side of the coin. Companies that are already
up and running have seen some problems. “Although the
number of new deals was steady, we were all too aware of the
struggles of many existing ventures to attract new capital or
stretch what they had to bridge the downturn.” And forces
around the country appear to be limiting the growth in biotech. According to the MoneyTree report from the accounting
firm PricewaterhouseCoopers, only seven companies went
public in the United States in January 2010 via initial public
offerings (ipos)—a big drop from the monthly average of
22.6 in 2007. In the United States, investment from venture
capital dropped from $4.4 billion in 2008 to $3.5 billion in
2009. The number of biotech deals also fell, from 501 in

2008 to 406 in 2009. (By contrast, 2007 saw 494 deals and
$5.3 billion in venture capital invested.)
“The state of biotech nationally, even internationally, is
in a difficult time right now because venture capital dollars
have dried up. [The economic downturn] makes everybody,
on paper, feel poorer. It makes [venture capitalists] more riskaverse,” says Paul R. Pescatello, j.d., ph.d., president and ceo
of Connecticut United for Research Excellence (cure), a nonprofit organization that supports bioscience in the state.
But Pescatello adds that other factors have taken a toll
on investment in biotech. The Sarbanes-Oxley Act of 2002,
enacted to combat corporate corruption, accounting fraud,
and mismanagement by extending government oversight of
public (though not of privately held) companies, makes it more
expensive to go public—especially for small companies. It’s
not always feasible, says Pescatello, “to go public and incur the
annual ongoing costs, the accounting costs, the auditing costs,
the disclosure costs. … You see fewer companies going public
to avoid that kind of regulatory and administrative burden.”
The debate over health care reform has also caused tension over patent life: the generic drug industry and lawmakers

The five companies financed in 2009:
Kolltan Pharmaceuticals
Kolltan, which has secured over
$35 million in financing, is developing monoclonal antibodies against
various cancers and hopes to move
these antibodies into clinical trials.

yale medicine spring 2010

founder
Joseph Schlessinger, ph.d., chair
and William H. Prusoff Professor of
Pharmacology

CardioPhotonics
The company is developing and
marketing technology that
provides real-time, noninvasive
blood volume monitoring.
founders
Kirk H. Shelley, m.d., ph.d., associate
professor of anesthesiology
David G. Silverman, m.d., professor of
anesthesiology

Advanced Orthopedic
Technologies
The company develops a series
of implants and regenerative
products for cartilage defect
repair and joint fusion.

MiraDx
Yale Cancer Center researchers
have pioneered a diagnostic test to
identify individuals predisposed to
lung, ovarian, and other cancers by
examining genetic biomarkers.

founder
John S. Reach Jr., m.d., assistant
professor of orthopaedics and
rehabilitation

founders
Frank Slack, ph.d., associate professor
of molecular, cellular and developmental biology in the Graduate School of
Arts and Sciences
Joanne B. Weidhaas, m.d., ph.d., assistant professor of therapeutic radiology

Oasys Water
The company is commercializing a
technology that employs osmosis
to produce fresh water from sea
water or industrial waste water and
uses 90 percent less energy than
conventional desalination systems.
founders
Rob McGinnis, a doctoral student in
environmental engineering in the Yale
School of Engineering and Applied
Science, and his advisor;
Menachem Elimelech, ph.d., chair
of the Department of Chemical
Engineering and Roberto Goizueta
Professor of Environmental and
Chemical Engineering
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like Rep. Henry A. Waxman, a California Democrat who chairs
the House’s Energy and Commerce Committee, are calling for
a five-year patent limit on biologics (medicinal products that
are made from living organisms) instead of the 12 years allowed
for pharmaceuticals. “If you only have five years to recoup
your investment,” Pescatello says, “no one’s going to invest
in biotech.”
Another poorly defined area in health care reform has
been reimbursement. How would biologics, pharmaceuticals,
and other drugs and devices be reimbursed under health care
reform? “That’s a big deal,” Pescatello says, because it’s impossible to establish price points without knowing what the system
will allow. “Investors hate uncertainty.”
William Wiesler, ph.d., director of new ventures at ocr,
agrees that uncertainty about pending legislation leads to
caution among investors. It happened in 1993: “When everybody was worried that Hillary Clinton was going to nationalize
medicine, all the pharma companies were down, and venture
capitalists got a little sour on biotechs. But that didn’t last too
long, and [investment] popped back up,” Wiesler says. “Some
industries have a cyclicality that’s a little bit different than

the rest of the market. And I am quite certain if the economy
finally turns around and picks up, and unemployment drops ...
and the nasdaq picks up that we’ll have another banner year
with the venture capitalists.”
Nurturing a young industry

Few people know New Haven biotech better than venture capitalist David Scheer, whose New Haven-based firm, Scheer &
Company, has helped to launch more than 10 biotech companies. His latest partnership with Yale is Axerion Therapeutics,
a company formed in 2009 in partnership with ocr and Yale
neurobiologist Stephen M. Strittmatter, m.d., ph.d. The company’s research efforts will focus on stimulation and regeneration of axons in the brain and central nervous system, with the
hope of reversing damage caused by traumas like spinal cord
injury and stroke.
But Scheer & Company does more than launch biotech
companies. “We’ve helped them in a variety of ways—recruiting,
fundraising, taking them through the usual rounds of private
financing, ipos, mergers and acquisitions transactions, business development, partnerships,” Scheer says. He has served on

Active companies in the New Haven area, and their founders:
Achillion Pharmaceuticals
Innovative treatments for infectious diseases (achillion.com)

Alexion Pharmaceuticals
Treatments for rare diseases
(alxn.com)

Axerion Therapeutics
Treatments for spinal cord injury
and Alzheimer disease

Carigent Therapeutics
Drug delivery technology
(carigent.com)

founder
Yung-Chi Cheng, ph.d., Henry Bronson
Professor of Pharmacology

founders
Leonard Bell, m.d. ’84, former assistant clinical professor of medicine
and pathology

founder
Stephen M. Strittmatter, m.d., ph.d.,
Vincent Coates Professor of Neurology
and professor of neurobiology

founders
W. Mark Saltzman, ph.d., chair and
Goizueta Foundation Professor of
Chemical and Biomedical Engineering

Affomix Corporation
Antibody screening technology
(affomix.com)

Joseph A. Madri, m.d., ph.d., hs ’76,
professor of pathology

founder
Michael Snyder, ph.d., former Lewis
B. Cullman Professor of Molecular,
Cellular, and Developmental Biology
and professor of molecular biophysics
and chemistry

Applied Spine Technologies
Spinal implant device
(appliedspine.com)
founder
Manohar M. Panjabi, ph.d., professor emeritus of orthopaedics and
rehabilitation

BioRelix
Antibiotic discovery (biorelix.com)
founder
Ronald Breaker, ph.d., Henry Ford II
Professor of Molecular, Cellular, and
Developmental Biology

Tarek Fahmy, ph.d., assistant professor
of biomedical engineering

cgi Pharmaceuticals
Kinase drug discovery
(cellulargenomics.com)
founders
David Armistead, ph.d.
Mark Velleca, m.d., ph.d., hs ’97, fw ’99,
assistant clinical professor of laboratory medicine
Ira Mellman, ph.d., former Sterling
Professor of Cell Biology and
Immunology
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the boards and as chair of all the New Haven-based companies
he’s helped to launch. “It used to be easier to raise money,” says
Scheer. “The capital markets are tighter.” In the current economic climate, he says, venture capitalists need to support their
existing portfolios. As a result less money is available for new
investments in the life sciences. “Only the strongest companies
are in a position these days to raise capital,” Scheer says.
A reputation in science

Just as Scheer nurtures his companies to success, Yale’s ocr
has learned over the years to shepherd biotech firms from a
notion in the lab to a full-fledged company with investors. ocr
was created in 1982 after Congress enacted the Bayh-Dole Act
of 1980, which allows universities to retain title to inventions
resulting from federally supported research. The office got
a boost in 1995 when the university tripled its budget and staff;
hired a new director; and charged the office with founding
and building local companies based on technology licensed
from Yale. In the last 10 years, ocr has helped Yale scientists
to found more than 40 companies that have in turn attracted
more than $450 million in financing. The university earns

CoolSpine llc
Cooling catheter for use in
cardiothoracic surgery

HistoRx
Quantitative histopathology testing and diagnostics (historx.com)

founder
John A. Elefteriades, m.d. ’76,
hs ’81, fw ’83, William W.L. Glenn
Professor of Surgery

founders
David L. Rimm, m.d., ph.d., professor
of pathology

Helix Therapeutics
Genetic repair therapies
(helixtherapeutics.com)

yale medicine spring 2010

founder
Peter M. Glazer, m.d., ph.d., Robert E.
Hunter Professor of Therapeutic
Radiology

Robert L. Camp, m.d. ’97, ph.d., associate research scientist in pathology

JS Genetics
Genetic tests for Turner’s syndrome
and dyslexia (jsgenetics.com)
founders
Jeffrey R. Gruen, m.d., associate professor of pediatrics (neonatology), investigative medicine, and genetics
Allen E. Bale, m.d., professor of genetics
Scott A. Rivkees, m.d., professor of
pediatrics (pediatric developmental
biology and biophysics)

between $10 and $20 million per year in royalties from the
commercialization of licensed patents. (ocr has tracked patent applications since 1987. Since then, there have been 5,897
applications filed and 1,483 patents issued in 54 countries.)
“We are actively pursuing a portfolio of 1,306 applications
worldwide,” says Diane K. Harmon, ocr’s director of intellectual property administration.
To Soderstrom, Yale’s reputation and strength in the
sciences is paramount. “Without quality science and technology,” he says, “you don’t have a whole lot to trade on. Yale is a
300-year-old institution, it’s considered to be one of the premier
research institutions in the world, [and it] has a faculty that
bespeaks that reputation.” Soderstrom cites the number of Yale
faculty belonging to the National Academy of Sciences—59
as of this writing—as a testament to the medical school’s depth
and excellence. “Particularly from the perspective of the
medical school, the quality of the technology, the quality of
the science that’s performed at the medical school, continues
to attract attention from investors and companies,” he says.
“And I think we’ve gained a pretty good reputation for identifying good ideas that people find worth investing in.”

L2 Diagnostics
Infectious disease diagnostics
founders
Erol Fikrig, m.d., Waldemar Von
Zedtwitz Professor of Medicine
Joseph E. Craft, m.d., professor
of medicine (rheumatology) and
immunobiology
Richard A. Flavell, ph.d., chair and
Sterling Professor of Immunobiology

Marinus Pharmaceuticals
Therapeutics for psychiatric
disorders (marinuspharma.com)
founder
Vincent A. Pieribone, ph.d., associate
professor of physiology

mgs Research Inc.

Medical gel dosimetry systems
(mgsresearch.com)

founders
Marek J. Maryanski, ph.d.
John C. Gore, ph.d., former professor
of psychology
Robert J. Schulz, ph.d., professor emeritus of therapeutic radiology

MiraDx
Cancer diagnostics
founders
Frank Slack, ph.d., associate professor
of molecular, cellular, and developmental biology
Joanne B. Weidhaas, m.d., ph.d., assistant professor of therapeutic radiology
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Although the New Haven region—home to about 50
biotech companies—enjoys a collaborative spirit, Connecticut
faces particular challenges. “We’re part of a growing community that sees a very strong need to help each other and
build out the economy of the area by investing in biotech,” says
Susan Froshauer, ph.d., fw ’88, founding ceo and currently
chief scientific officer of Rib-X Pharmaceuticals. The company
aims to bring to market small-molecule antibiotics based on
the work of 2009 Nobel laureate Thomas A. Steitz, ph.d.,
Sterling Professor of Molecular Biophysics and Biochemistry
and professor of chemistry; Peter B. Moore, ph.d., Sterling
Professor of Chemistry and professor of molecular biophysics
and biochemistry; and William L. Jorgensen, ph.d., Sterling
Professor of Chemistry. “In environments such as San Diego
or Boston, there’s a larger critical mass,” Froshauer says, “and
so there’s more of a momentum that has been sustainable,
even through hard times.”
Whether Connecticut has a pool of talent large enough
to meet the local need is a sticking point. In Connecticut
and at Yale, says Scheer, “there is absolutely no dearth of
great technology. But one of the critical issues that we have

found over the years is recruiting ceo talent. Some of the more
business-oriented pharmaceutical executives tend to be in
other places. They have their families, kids, et cetera, in places
like Princeton or Boston or New Jersey or the Bay Area, and
they just don’t want to move.”
But New Haven’s biotech economy is also a young one.
“When you’re talking about size, we’re never going to be that
[large],” says Soderstrom, referring to more established biotech
centers around the country. “What we can do is be really good
at what we have.” Soderstrom says the local market has begun
to sustain itself, so ocr no longer needs to be chiefly responsible for all new ventures. “There was a time when we were
putting together the PowerPoint presentations, making the calls
to the investors, doing the pitch with investors, helping to
recruit the talent, actually negotiating leases on space. We don’t
have to do a lot of that stuff anymore, because there’s already
talent stepping in and doing those kinds of things.” YM

New Haven Pharmaceuticals
Therapeutics for depression and GI
disorders (newhavenpharma.com)

PhytoCeutica
Traditional Chinese botanical
remedies developed into fdaapproved drugs for cancer
(phytoceutica.com)

founders
John H. Krystal, m.d. ’84, hs ’88,
Robert L. McNeil, Jr., Professor of
Clinical Pharmacology
John P. Geibel, m.d., ph.d., associate
professor of surgery (gastroenterology)
Wajahat Z. Mehal, ph.d., assistant professor of medicine (digestive diseases)
Gerard Sanacora, m.d., ph.d., assistant
professor of psychiatry
Vladimir Coric, m.d., associate clinical
professor of psychiatry

Optherion
Therapeutics and diagnostics for
age-related macular degeneration
(optherion.com)
founder
Josephine J. Hoh, ph.d., associate
professor of epidemiology and
ophthalmology

PGxHealth, a division of
Clinical Data
Biomarker discovery and drug
development (pgxhealth.com)
founder
Gualberto Ruaño, m.d. ’97, ph.d. ’97

Charles Gershman is an assistant editor at Yale School of Medicine’s office of
Institutional Planning and Communications.

founder
Yung-Chi “Tommy” Cheng, ph.d., Henry
Bronson Professor of Pharmacology

Rib-X Pharmaceuticals
Antibiotic drug discovery and
development (rib-x.com)
founders
Thomas A. Steitz, ph.d., Sterling
Professor of Molecular Biophysics and
Biochemistry (and co-recipient of the
2009 Nobel Prize in Chemistry)
Peter B. Moore, ph.d., Sterling Professor
of Chemistry and professor of molecular biophysics and biochemistry
William L. Jorgensen, ph.d., Sterling
Professor of Chemistry

SurExam
Ovarian cancer diagnostics
for Chinese market
founder
Gil G. Mor, m.d., m.sc., ph.d., associate
professor of obstetrics, gynecology,
and reproductive services

Vascular Insights llc
ClariVein catheter for treating varicose veins (vascularinsights.com)
founders
John P. Marano Jr., ph.d. ’69
Michael Tal, m.d., associate professor
of radiology
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Science
by Design
As research becomes more
interdisciplinary, architects
are designing buildings
that foster collaboration.
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By John Dillon
Illustrations by Shane McGowan
After 15 years in his warren of offices and lab space on the sixth
floor of the Laboratory of Epidemiology and Public Health,
where he studies how ticks spread Lyme disease and ehrlichiosis, Durland Fish, ph.d., has grown fond of its dark nooks
and labyrinthine passageways. But by 2008 plans were in the
works for renovations that would transform the floor into a
more open, communal atmosphere—and pull Fish, professor
of epidemiology, into the 21st-century world of science architecture. “Renovations have to be done,” he conceded. “I personally
am not looking forward to it.” New interior windows will make
the floor more transparent, and Fish doesn’t want to think he’s
working in a fishbowl. “I don’t want anybody peeking in and
seeing what I’m doing,” he said. “I want to get my work done
in my own way and not be bothered.”
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p r e v i o u s pag e Although
many scientists have grown used
to working in a warren of offices
and laboratories, a new philosophy
in laboratory design promotes
interaction among disciplines and
encourages collaboration.

But science and architecture are moving in a new direction—away from the era in which a laboratory was built to
order for a single principal investigator. While both new buildings and renovations to older ones aim to provide more support
space for scientists, they also offer flexibility. Designed more
like mittens than gloves, modern lab buildings include a little
wiggle room. More ample common areas encourage mingling
among scientists. And if a researcher departs for new academic
pastures, their space can easily accommodate a new scientist.
Yale has been on an ambitious quest to increase lab
space and improve its existing labs since the early 2000s. The
Anlyan Center, which opened in 2003 at a cost of $172 million, was a major step. Its 450,000 square feet increased the
school’s research space by 25 percent. The Amistad Street
Building, which opened in 2007 with an $88-million price
tag, added another 120,000 square feet. The school also spent
$14 million in 2002 on a 23,700-square-foot extension of
the Sterling Hall of Medicine’s B wing. By 2011, the school
will have spent an additional $467 million in renovations to
various lab buildings, not including Amistad, The Anlyan
Center, and the B wing extension, or the West Campus in
neighboring Orange and West Haven. Because of the economic slowdown, plans for renovations to the West Campus
have slowed down and construction of a new building on
the main medical campus is on hold. The medical school is
awaiting word on applications to nih for construction funding for other projects.
Despite these expansions, the way in which space is distributed and used by researchers remains an issue. The new
philosophy in interior design promotes interaction among disciplines and provides more comfortable digs for collaboration
to take place. At the same time, the new spaces segregate
offices from laboratories, partly to discourage researchers from
eating in their labs—food can contaminate experiments—but
also to allow reconfigurations as circumstances change.
In the past, said M. Virginia Chapman, m.arch. ’85,
director of construction and renovation for facilities at
the School of Medicine, “every lab was tailored to the specific
needs of the researcher. … It was so specific that you had to
do a comprehensive renovation when a new user came in.”
And, said Reyhan T. Larimer, project manager for facilities construction and renovation at the School of Medicine,
noting the often transient nature of academic life, “The major
trend in lab design is generic, flexible design.”

And that’s why a “plug-and-play” approach guides the
design of lab modules, said architect J. Ian Adamson, a
principal with Payette Associates of Boston—the firm that
co-designed The Anlyan Center and designed the additions
to the Sterling Hall of Medicine’s B wing. “As people come
and go and research ebbs and flows, you’re not doing a lot
of renovation. It looks like an Erector Set. These [new labs]
are easy enough that the principal investigators could change
things on a weekend and not have to put in a requisition order.”
Desks, tables, and benches in the Amistad Street Building, for
instance, are on casters and can be reconfigured easily. The
generic design “stops some 800-pound gorilla from saying,
‘I want to do the lab,’ and when he retires, they’re stuck with
this idiosyncratic lab,” Adamson said.
Academic fiefdoms are “a battle we deal with all the
time” in building renovations, said Michael E. Schrier, project
manager for facilities construction and renovation at the school,
who has overseen renovations to many of the older structures.
Once the building is renovated, the facilities “are turned over to
the assigned department. If within five years Department A
left, Department B could come in with little or no work at all.”
As science has changed, so has another element of lab
design: support space. Historically, architects had set aside
30 square feet of support space for every 100 square feet of lab
space; however, that ratio increased even as The Anlyan Center
was under construction. Part of Schrier’s job is to make room
by squeezing utilities that were once out in the open—plumbing, electrical, and computer lines—into walls and ceilings.
With scientists spending more time at computers and in controlled environments, newer designs require that each square
foot of lab space be matched by a square foot of support space.
“We’re finding that far more time is spent in these specialized
support rooms than on the benches, hence the shift in the
ratio,” said Adamson. Temperature and humidity control have
become more important in many fields, and “air displacement
can have a huge effect.”
The school takes pains to give researchers what they
need, said Chapman, while Larimer added, “You have to
remind them that it’s a generic space.”
Flora M. Vaccarino, m.d., a professor in the Child Study
Center, said she was happy to see renovations under way at
Sterling’s I-Wing, where her lab investigates the responses of
neural stem cells to genetic and environmental factors; but she
wondered about the allocation of space. As priorities change
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with funding, space needs in laboratories also change. “What
happens when labs undergo major changes in research directions?” Vaccarino asked.
A square peg in a round hole

The Amistad Street Building, which opened in 2007, offers
an example of both the new philosophy at work and the
perennial space problems facing the medical school. Amistad
became a starter home for the Yale Stem Cell Center as
well as the Human Translational Immunology program and
the Vascular Biology and Transplantation program. In less
than three years, however, the Stem Cell Center, which had
been scattered around the campus, has expanded to six
independent research laboratories and eight faculty members
housed in roughly 30,000 square feet. “We have four new
recruits,” said Diane S. Krause, m.d., ph.d., associate director of the center. “Now that they’ve moved in, we will soon
be bursting at the seams.”
Krause, a professor of laboratory medicine, cell biology,
and pathology, appreciates the communal aspect of the
Amistad building, which has lounges in the middle of the
floors where researchers can gather. “It is nice to have these
opening areas where people can interact,” she said.
Creating such gathering spots is a key element in
designing new research space. “Where will the next Nobel
Prize project develop?” said Robert Venturi, whose firm
Venturi, Scott Brown and Associates co-designed The Anlyan
Center. “In the lab? The meeting space? The café?”
To create that common shared space, The Anlyan Center
is split into two wings—three stories for teaching and six stories for research—that are connected by walkways and share
a lobby. The purpose of the lobby “was to simulate a street
going through, a communal space between two buildings,”
said Larimer. In the research wing, 450-foot-long corridors end
in lounges that are part kitchenette, part cafeteria, and part
mini-lecture hall. Blackboards (which won the battle against
whiteboards in this instance) dominate one wall opposite fixed
benches, with tables and chairs scattered about. The benches
were added so that researchers could catch forty winks. “You
get folks who are in these buildings for long hours,” Adamson
said. “If you build these lounges, they can lie down and
stretch out for two hours.”
Promoting multidisciplinary chats at the water cooler is
not an attempt at social alchemy; it was born from necessity.

“Science itself is becoming more interdisciplinary,” Adamson
said. “Boundaries between departments are breaking down
across the board.”
At The Anlyan Center, corridors and even the stairway
landings act as meeting spaces, whether planned or impromptu.
X-ray readers, for example, are in the hallway outside the
anatomy teaching lab to promote group discussions.
The lengthy corridors that bisect Anlyan separate offices
and research spaces; in Amistad, the offices are bookends
between the labs. “In the old days, you could have your office in
the labs,” Chapman said. “That’s something that’s hard to do
now. The idea is to create open laboratories to allow for flexibility. If you insert offices midway through these labs, you create
labs that cannot grow or contract with research needs.”
The medical school has heard some grumbling about
the division. “People don’t like having their offices remote from
their labs,” Chapman said, “so we try to make the offices as
close to the labs as possible.” Since food and beverages aren’t
allowed in the labs, shelving units or “coffee cubbies” are
placed outside each lab so researchers can store a cup of coffee
or other food items while they are in the lab. (At the newer
Amistad Building, the “coffee cubbies” are tall enough to
accommodate a Starbucks venti-sized cup.)
Fostering that water cooler collegiality, however, requires
more than redesigning the physical plant. Jeffrey R. Bender,
m.d., the Robert I. Levy Professor of Medicine (cardiology)
and professor of immunobiology, notes that such labs as his,
at the end of a corridor at The Anlyan Center, tend to be selfcontained. And the labs between the ends might be occupied
entirely by a senior faculty member with abundant grants.
Such labs, Bender said, could have up to 36 work stations for
one PI. “An assistant professor is going to get four to eight work
stations,” he said.
And that’s where the interactions are likely to occur—in
a large lab space occupied by up to half a dozen assistant professors and their lab groups. “Their graduate students and postdocs are going to be sharing the same space,” Bender said.
Girish Neelakanta, ph.d., a postdoctoral fellow in infectious disease, has worked in such a lab in The Anlyan Center
for four years and finds it encourages collegiality in several
ways. One is its location near other lab buildings. And within
the building itself, he said, it’s easy to talk to other scientists.
His first-floor lab, where he works on Lyme disease, is shared
by four principal investigators.
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New ideas in lab design encourage
interdisciplinary cross talk and
collaboration through common
areas that lend themselves to
“water cooler” conversations.

“Here we are all friendly. We share a lot of equipment,”
he said. “You can talk to postdocs working on different projects.”
Sarojini Adusumilli, ph.d., also a postdoc in infectious
disease, echoes Neelakanta’s comments. “We share ideas with
people when we meet in the break room,” she said. “The break
room is a place where we talk about science. Maybe someone
saw a paper and they thought it was interesting. We also discuss the problems of science and the kind of work we do.”
But the building’s layout also encourages interdisciplinary conversations. “Doctors and postdoctoral researchers can all
interact,” she said. “People working in basic science as well as
clinical science can discuss things.”
A few miles away, the interdisciplinary approach is driving plans for the West Campus. Built in several stages over a
period of years, the former Bayer facility has almost half a
million square feet of pristine lab space for both biology and
chemistry researchers. Unlike spaces on the medical school
campus, West Campus will not be home to generic labs but
to specialized core facilities and new institutes dedicated to
specific fields of research. George Zdru, director of capital
programs at the medical school’s facilities office, notes that so
far three core research facilities—the Yale Center for Genome
Analysis, the Center for High Throughput Cell Biology, and
the Small Molecule Discovery Center—have opened up on the
West Campus with few modifications to existing space. Five
institutes are in the preliminary stages of planning—microbial
biology, chemical biology, cancer biology, systems biology, and
cell biology. “At this point it is hard to tell how much restructuring will be required,” Zdru said. “The West Campus in its
totality is being thought of as a multidisciplinary environment
by the nature of the definition of the institutes. The three primary research buildings are interconnected. Inherently, there is
a multidisciplinary nature to the planning of West Campus.”
A room with a view

More glass and better lighting are dominant features in both
the new buildings and the refurbished ones on the medical
school campus. A driving force behind that is Yale’s sustainability initiative that aims to reduce energy use. But the school
also desires more openness in its labs, which had been “like
rabbit warrens,” Chapman said.
At The Anlyan Center some interior windows have been
treated with translucent film or otherwise covered to offer privacy for occupants who don’t want everything they do on public

display. Most labs, however, retain their original openness.
Because the building was designed for transparency, it was left
up to the departments and researchers to either keep it that
way or have a modicum of seclusion.
Venturi said that science buildings should have work
spaces near windows at the building’s exterior “for enjoying the
amenity of natural light and the view,” while the mechanical
space belongs in the center and on the top. The Anlyan Center,
whose architecture is based on that of an old New England
mill, follows that thinking even in the third-floor anatomy lab.
“Because it has a lot of windows, it was controversial,” Adamson
said. “We thought it was important to have natural light in
there. If you’re stuck in a windowless room six hours a day,
it’s depressing.”
Though Adamson said that most scientists are “more
than happy to work in a shared space,” not everyone is fond
of breaking the labs open; some researchers still prefer their
warrens and cubicles.
“That attitude is really waning,” said Bender. “You can
have a chunk of space that you feel is your own. It is more
generic and it’s more flexible. If you need two extra benches,
you don’t need to invade someone else’s room.” YM
John Dillon is a freelance writer in New Haven.
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Frederick
Haeseler

notes

Peter Ellis

Janet Hafler

Murat Günel

Change in primary
care clerkship

New assistant dean
for education

frederick d. haeseler, m.d.,
fw ’76, has stepped down as head

janet p. hafler, m.ed., ed.d.,
has been appointed assistant dean
for educational scholarship in the
office of education. Hafler, who
began her career as a registered
nurse, earned a master’s degree in
education from Teachers College
of Columbia University and a doctorate in education from Harvard
University. Hafler comes to Yale
with extensive experience in the
medical schools of Harvard and
Tufts, where she worked in faculty
development. At both schools
she addressed teaching, learning assessment, and curriculum
development. At Yale Hafler will
work with faculty and residents
to improve teaching and learning.
She will develop and implement
educational programs and individual educational consultations, and
work on defining and evaluating
educational contributions.
One new program she plans
to start is a fellowship for faculty
in medical education. The project
will begin in July with one or two
faculty members from each of five
departments. Each participant will
design a resident-as-teacher program for training residents to teach
medical students as well as fellow
residents. Hafler is also developing
metrics for evaluating teaching.
Richard Belitsky, m.d., deputy dean
for education, noted that Hafler’s
appointment coincides with the
medical school’s decision to review
its curriculum with an eye toward
strategic revisions. “There was a
clear consensus,” he said, “to bring
to Yale someone with expertise in
medical education who is trained
as an educator.”

Murat Günel, m.d., hs ’98, has
been named the Nixdorff-German
Professor of Neurosurgery. Günel,
also professor of neurobiology
and of genetics, is co-director of
the Yale Neurogenetics Program
and studies genetic risk factors
for neurovascular disease. He received his medical degree from
Istanbul School of Medicine in
Turkey and completed his residency
in neurosurgery at Yale-New
Haven Hospital in 1998. That same
year, he joined the School of Medicine faculty as an assistant professor of neurosurgery. Günel
has been chief of the Section of
Neurovascular Surgery since 2001
and a full professor of neurosurgery since 2008.

of the fourth-year primary care
clerkship that he has directed since
1993. peter j. ellis, m.d., m.p.h.,
assistant professor of medicine,
took over effective January 1.
Haeseler founded the clerkship in 1993 with a grant from the
Robert Wood Johnson Foundation
for curriculum reform. The goals
of the reform included increasing
medical student exposure to primary care and developing outpatient educational sites for clinical
clerkships. The present month-long
clerkship includes a combination
of faculty-led discussion groups on
key primary care topics and supervised patient care in communitybased practices and clinics.
The transition comes as the
medical school begins a strategic
planning process covering the
entire four-year curriculum. Ellis
is interested in exploring several
contemporary themes in primary
care, including the patient-centered
medical home, outpatient clinical
reasoning, and cost containment.
One of the principal goals of the
clerkship, said Ellis, is to “enable
students to perform an accurate
problem-focused patient assessment in an ambulatory setting.”
Haeseler will continue to direct
the standardized patient program
that he also founded in 1993. He
writes scripts for the program and
trains actors to portray patients
with a variety of medical disorders.
Medical students then interview
and examine the standardized
patients to learn and practice clinical skills. Haeseler will also continue
to mentor students as an attending
physician at haven, the studentrun free clinic in New Haven’s Fair
Haven neighborhood.

David Hafler

David A. Hafler, m.d., chair
of neurology at the School of
Medicine, has been named the
inaugural Gilbert H. Glaser, m.d.,
Professor of Neurology. Hafler,
a leader in the effort to better
understand the molecular basis of
multiple sclerosis, joined the faculty in September. An authority
on the mechanisms of autoimmunity and inflammatory diseases
of the central nervous system,
he was previously director of
molecular immunology in the
neurology department of Harvard
Medical School, where he was the
Jack, Sadie, and David Breakstone
Professor of Neurology (Neuroscience) and a neurologist at
Brigham and Women’s Hospital.
Hafler also received the John J.
Dystel Prize for Multiple Sclerosis
Research from the American
Academy of Neurology in January.
The prize is given in recognition
of his outstanding achievements
in multiple sclerosis research. The
award comes with a $15,000 prize.

Steven Leder

Ruslan
Medzhitov

Steven B. Leder, ph.d., professor of
surgery (otolaryngology), has been
installed as the incoming president
of the Dysphagia Research Society
for 2010-2011. The society is an international organization devoted
to all aspects of swallowing and
its disorders. Leder is involved in
clinical care. He also does research
in dysphagia diagnostics and rehabilitation for patients with head
and neck cancer, as well as other
acute and long-term diseases,
voice restoration following total
laryngectomy, and voice rehabilitation following tracheotomy
and ventilator dependency. Leder
received his doctorate from the
University of Connecticut and is a
fellow of the American SpeechLanguage-Hearing Association.
Ruslan Medzhitov, ph.d., the
David W. Wallace Professor of
Immunobiology and a Howard
Hughes Medical Institute Investigator, has received the 2010
Lewis S. Rosenstiel Award for
Distinguished Work in Basic
Medical Science. The award was
conferred for Medzhitov’s “elucidation of the mechanisms of
innate immunity.” Medzhitov’s
studies helped shed light on
“the critical role of Toll-like receptors (tlrs) in sensing microbial
infections, mechanisms of tlr signaling and activation of the inflammatory and immune response.”
Rosensteil Awards are given to
scientists for recent discoveries
of particular originality and importance to basic medical research.
A $30,000 prize and a medal
accompany each award. Sharing
the award for his work in innate
immunity is Jules Hoffman, ph.d.,
Research Director and Member
of the Board of Administrators of
the National Center of Scientific
Research, University Louis Pasteur, Strasbourg, France.
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Andres Martin

Carolyn Mazure

Past Yale winners of the
Rosenstiel Award include: in
2008, Arthur L. Horwich, m.d.,
Eugene Higgins Professor of
Genetics and Pediatrics and
Howard Hughes Medical Institute Investigator, for his work
in the field of protein-mediated
protein folding; in 2002, Joan A.
Steitz, ph.d., Sterling Professor
of Molecular Biophysics and Biochemistry and Howard Hughes
Medical Institute Investigator,
for her work in establishing a
subfield of molecular biology
concerning small nuclear ribonucleoproteins; in 2001, Thomas A.
Steitz, ph.d., Sterling Professor of Molecular Biophysics and
Biochemistry and Chemistry and
Howard Hughes Medical Institute
Investigator, who later won the
2009 Nobel Prize in Chemistry;
in 1989, Sidney Altman, ph.d.,
Sterling Professor of Molecular,
Cellular, and Developmental
Biology, for discovering the
catalytic properties of rna.
Altman won the Nobel Prize in
Chemistry the same year.
Andres S. Martin, m.d.,
m.p.h. ’02, was appointed the

Riva Ariella Ritvo Professor of
Pediatric Psychosocial Services in
December. Martin, an associate
professor of child psychiatry
and psychiatry in the Yale Child
Study Center, is also the medical
director of the Children’s Psychiatric Inpatient Service at YaleNew Haven Children’s Hospital.

Carolyn M. Mazure, ph.d., professor of psychiatry and psychology
and associate dean for faculty
affairs, was inducted into the
Connecticut Women’s Hall of
Fame in October for her work

Kevin Pelphrey

Nancy Ruddle

that explores gender-specific
differences in the causes, treatment, and prevention of cancers,
osteoporosis, depression, and
other disorders more prevalent
in women. Mazure created the
Women’s Health Research at Yale
(whry) program in 1998 based
on the premise that understanding gender differences is vitally
important to the health of both
women and men. whry—which
Mazure began with a grant from
the Patrick and Catherine Weldon
Donaghue Medical Research
Foundation of West Hartford—
has grown to become a national
model for conducting research
on women’s health and disseminating findings with real-world
benefits to the community.
Kevin Pelphrey, ph.d., has been
named the Harris Family Associate Professor of Child Psychiatry in
the Child Study Center. Pelphrey
studies brain mechanisms underlying the development of different aspects of social cognition.
His interests include the development of social perception, the
perception and regulation of
emotion, and the development
of theory of mind—a crucial
cognitive capacity defined as the
ability to make inferences about
the mental states of others.
Pelphrey completed his doctorate
in psychology at the University
of North Carolina, Chapel Hill, in
2001. He then held a postdoctoral
fellowship in cognitive neuroscience at Duke University. He
remains a core faculty member of
Duke University’s Brain Imaging
and Analysis Center. Pelphrey is
a frequent collaborator with colleagues in Yale’s Department of
Psychology; he is also a member of the Interdepartmental
Neuroscience Program and the
Cognitive Science Program.

Gerald Shulman

Robert White

Nancy H. Ruddle, ph.d. ’68,
professor emerita and senior
research associate in the Division
of Epidemiology of Microbial
Diseases in the School of Public
Health, received the 2009 Lifetime Achievement Award from
the International Cytokine Society
at its annual meeting in Lisbon,
Portugal, in October. The award is
given annually to a scientist who
has contributed to research on
cytokines, proteins released by
cells within the immune system
that are critical to regulating
the body’s immune response.
Ruddle’s research, which began
during her years as a graduate
student in microbiology at Yale,
focuses on lymphotoxin and
other cytokines involved in autoimmune diseases and lymphoid
organ development.
Gerald I. Shulman, m.d., ph.d.,
the George R. Cowgill Professor of
Physiological Chemistry, professor of medicine and of cellular
and molecular physiology and a
Howard Hughes Medical Institute
Investigator, was named a fellow
of the American Association for
the Advancement of Science
(aaas) in December. He is one of
531 aaas members elevated to
this rank last year for their efforts
toward advancing science applications that are deemed scientifically or socially distinguished.
Shulman was honored for his
contributions to the understanding of type 2 diabetes, notably the
mechanisms of insulin resistance
and the metabolic syndrome, a
cluster of risk factors for diabetes
and heart disease.

William V. Tamborlane, m.d.,
fw ’77, professor and section
chief of pediatric endocrinology
and deputy director of the Yale
Center for Clinical Investigation,
has been honored with the Diabetes Technology Leadership award
by the Diabetes Technology
Society for his lifetime accomplishments in diabetes research
and technology. Tamborlane’s
achievements have included pioneering work in the development
of insulin pump therapy, continuous glucose monitoring, sensoraugmented pumps, closed-loop
systems, and development of
an artificial pancreas. He also
demonstrated the role of insulin
resistance in pediatric metabolic
disorders, including obesity and
type 2 diabetes.
Robert I. White, m.d., professor of
diagnostic radiology, received the
2010 Career Achievement Award
from the International Symposium on Endovascular Therapy
at its annual meeting in Florida
in January. White, the director of
the Yale Vascular Malformation
Center, is credited with developing
four new procedures in vascular
interventional radiology, including embolization of pulmonary
arteriovenous malformation
and varicocele, and percutaneous valvuloplasty for pulmonary
valve stenosis and coarctation
restenosis. He has authored two
textbooks and more than 300 papers. His honors include a Gold
Medal and Leaders in Innovation
award from the Society of Interventional Radiology, of which he
is a past president.
send facult y news to
Claire M. Bessinger, Yale Medicine,
300 George Street, Suite 773,
New Haven, CT 06511, or via e-mail
to claire.bessinger@yale.edu
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students
recession-proof” because their skills are
in such demand. Physician associates,
he said, can help solve several of the biggest problems in health care, such as the
shortage of physicians, the expanding
need for health care, and rising costs.
All of these issues will be intensified, he
added, once Congress passes a health
care reform bill that could bring 30 million currently uninsured people into the
health care system.
Galvin advised the graduates to
become lifelong learners, because the
ongoing explosion in medical knowledge constantly renders old information
obsolete. He also urged them to treat
their patients with kindness.
Three students were given special
honors: Dominique Caruso received
the Dean’s Academic Award for excellence in the classroom; Lauren Swisher
received the Dean’s Clinical Award for
distinction in the clinical portion of the
program; and Megan Dieterich won the
Dean’s Humanitarian Award for volunteer work at the haven free clinic.
The students also gave three awards
of their own: to Rex L. Mahnensmith,
m.d., professor of medicine, for excellence as a teacher; to the Clover Fork
Clinic in Evarts, Ky., for providing
exemplary clinical teaching; and to
Rita Rienzo, pa-c, m.m.sc., assistant
professor in the Physicians Associates
Program, who accepted the Jack Cole
Society Award for her support of students and the profession.
Robert J. Alpern, m.d., dean of the
Yale School of Medicine and Ensign
Professor of Medicine, congratulated the
graduates and handed out the diplomas.
And lastly, as a sonorous recessional was
played on the Woolsey Hall pipe organ,
35 new physician associates marched
down the aisle past beaming families
and friends.
—Steve Kemper

New PA grads face
a bright future

Physician associates can help solve
some of the biggest problems in
health care.

t o p Robert Galvin, chief medical officer of General Electric, told physician associate graduates that
they can help solve some of the biggest problems
in health care, such as the shortage of physicians.
a b o v e Dean Robert Alpern awarded a
diploma to Dominique Caruso.
r i g h t Students Carolyn Canonica, Emily Burgun, Nicholas Bonomo, and Sarah Bailey waited
for the procession into Woolsey Hall to begin.

j o hn c u r t i s ( 3 )
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“It’s a great time to be a physician
associate,” said Robert S. Galvin, m.d.,
in a Commencement address given
in December to 35 new graduates of
Yale’s Physician Associate Program.
Galvin, the executive director of
health services and chief medical officer
of General Electric, told the graduating
class that their profession is “close to
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Tarot card readings, a vintage Epiphone
guitar, a chance to challenge the dean’s
softball team, and an afternoon of handy
work by second-year medical students
were on the block on Nov. 19 at the 17th
Annual Hunger and Homelessness
Auction sponsored by the Yale Health
Professional Schools.
This year the auction netted about
$25,000 for local nonprofits whose programs combat hunger and homelessness.
In the past, grants have been awarded
to such agencies as the Community
Health Care Van, Loaves and Fishes, the
Community Soup Kitchen, and Domestic
Violence Services.
Traditional items were offered
during the live auction in Marigold’s,
including a bow tie belonging to
William B. Stewart, ph.d., associate
professor of surgery and chief of the
Section of Anatomy and Experimental
Surgery. (The tie, which “smells
faintly of formaldehyde,” fetched
$900.) Stewart also offered his usual
Beef and Beer Dinner for eight, which
fetched an additional $900. Nancy R.
Angoff, m.p.h. ’81, m.d. ’90, hs ’93,
associate dean for student affairs, and
Margaret J. Bia, m.d., professor of
medicine, reprised their “Girls’ Night
Out”—“Share good food, great company, juicy gossip, and worldly wisdom
with Drs. Peggy Bia, Jean Vining, Joni
Hansson, and Nancy Angoff. (Dinner
for girls only).” The dinner was worth
$800 to a group of medical students.
And continuing into his fourth
year, Wade Brubacher, a professional
auctioneer from Kansas and father

j o hn c u r t i s ( 3 )

Hunger and Homelessness
Auction raises funds for local
organizations

of medical student Jake Brubacher,
offered his services and led the bidding.
The live auction came after a
silent auction that began on Monday,
Nov. 16. The silent auction included
offerings of clothing, dinners, food,
and lessons in language, arts, dance,
and sports. Assorted services offered
included trips to Costco, gofer services
for one business day, computer help,
and a personal tour of the Big Apple
from a native New Yorker.
—John Curtis

t o p Medical student Stacey Kallem offered a
bid on a “girls’ night out” with faculty including
Nancy Angoff and Margaret Bia.
a b o v e l e f t Nursing students Katherine
Magoon, Meaghan Hamilton, and Emily Miller
perused the list of items before the start of
the live auction.
a b o v e r i g h t Auctioneer Wade Brubacher
cajoled first-year medical student Nathan
Pirakitikulr into making a bid.
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Keeping body and
soul together

m a r i o n s . w h el a n

For one doctor, history and the
other humanities are a vital part
of medicine.
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Edward Halperin, dean of the School of Medicine
at the University of Louisville, believes that
knowledge of the cultural, historical, and philosophical underpinnings of medicine is essential
to medical education.

If you type the name “Halperin EC”
into the medical journal search engine
PubMed, the results—nine pages
worth—seem to be the works of different authors. There are articles about
brain tumors and radiation treatments.
But then there’s one about the theft
of the bodies of African Americans
for anatomy classes in the late 18th
and early 19th centuries. There is one
entitled “The pornographic anatomy
textbook?” And there is “Should academic medical centers conduct clinical
trials of the efficacy of intercessory
prayer?” All were written by Edward
C. Halperin, m.a., m.d. ’79, a pediatric radiation oncologist, dean of the
School of Medicine at the University of
Louisville, Ky., and a passionate devotee
of the liberal arts.
“Physicians like to be convinced
that they’re rarified and scientific,”
Halperin said, “but medicine is a social
activity that takes place in the context
of its times.” Knowledge of the cultural,
historical, and philosophical underpinnings of medicine, he believes, is central
to medical education. When he became
dean at Louisville in 2006, Halperin
instituted three compulsory humanities classes for medical students—
Intersection of Religion and Medicine,
History of Medicine, and Literature
in Medicine—and helped start a joint
m.d./m.a. in medical humanities there.
He earned a master’s in liberal studies
himself while at his previous post as vice

dean of Duke University’s School of
Medicine, attending classes like The
Human-Animal Boundary, Travel Writing in the Ancient World, and South
African History.
For his master’s thesis on drug
screening of medical residents, he asked
doctors-in-training at Duke whether
they thought drug tests violated their
civil rights. They didn’t, it turned out.
“Interns and residents are so acculturated to jumping through hoops, that if
you say ‘Urinate in the cup,’... They say,
‘Which way is the bathroom?’ ” He is
troubled by evidence that criminal background checks on medical students are
racist—minor crimes like marijuana
possession can lead to very different consequences for minorities as opposed to
affluent whites. And he is leery of medical students doing “audition electives” at
faraway hospitals in the hopes of matching at competitive residencies, since the
inherent expense discriminates against
less affluent students.
A native of Somerville, N.J., Halperin
developed a passion for ethics and human rights in childhood. He idolized
lawyers, including a relative who sat on
New Jersey’s Supreme Court, as well as
then-Justice Department lawyer Nicholas
Katzenbach. Katzenbach’s 1963 “schoolhouse door” confrontation with Gov.
George Wallace, who opposed desegregation at the University of Alabama, deeply
impressed Halperin. After seeing photos
of the event, he decided to become a civil
rights lawyer. Eventually, though, he
realized that most lawyers don’t wind up
on supreme courts or engaged in historic
civil rights struggles. “I might end up
having to do parking tickets, divorces,
house closings,” he remembers thinking.
“That might not make a really big difference in society.
It was then that Halperin turned
to medicine. He chose radiation oncology in part because he felt it was one
of the most consequential, high-stakes
things a doctor could do. He trained at
Stanford and at Massachusetts General
Hospital and is now an authority on
childhood cancers.
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The granddaughter of a
legend finds her own way
as a physician

The patients Halperin cares for are
indeed those who force doctors to think
about whether the world makes sense.
“Doctors have a lot of rationalizations
that get them through the day,” he said.
A long-time smoker with untreated
hypertension who has a stroke, or a
woman with cervical cancer who had
dozens of sexual partners and never
got a Pap smear may prompt a doctor
to privately rationalize that the patient’s
irresponsibility is to blame. “But there’s
nothing to blame when a 7-year-old has
leukemia,” he said. “Children with cancer bring up the problem of evil.”
Medicine and the humanities are
part of the culture of Halperin’s family.
His wife, Sharon, and his eldest daughter, Rebecca, are physical therapists; the
two of them recently volunteered their
expertise in Nicaragua. His middle
daughter, Jennifer, works in fashion
as a dress buyer for Victoria’s Secret,
while his youngest, Alison, is a senior
at Barnard College and studies limb
injuries and artificial limbs during the
Civil War.
That interest in medical history is
part of the cultural legacy Halperin
tries to impart to his students. One of
his most remarkable articles concerns
a 1971 anatomy textbook that included
chauvinist remarks and photographs
of women in an alluring pin-up style;
the textbook met with outrage and
was withdrawn soon after publication.
“The story of discrimination against
blacks and Jews and Catholics and
women is part of the story of medicine,
and is worth telling,” he said. “If we fail
to tell these tales and remember our
history, we’ll be the worse for it.”
—Jenny Blair, M.D. ’04

Sally Winternitz, m.d., hs ’86, grew
up in northern New Jersey consumed
by things that are typically only
passing fancies for little girls—riding
horses, playing in the woods, and
collecting shells. At 16, her passions
took a turn when she decided that
she wanted to attend medical school.
“I didn’t think of it as being part of
a family tradition,” she said. Whatever
the spark, Winternitz’s decision
continues a rich heritage of medicine
initiated by her ancestors.
Winternitz’s grandfather, Milton
Charles Winternitz, m.d., a secondgeneration physician, reigned as dean
of the School of Medicine from 1920
to 1935, during which time he boosted
the school to elite status and established
the Yale system of medical education. Her grandmother, Helen Watson
Winternitz, m.d., earned her medical
degree at Johns Hopkins before marrying Milton, although she declined to
practice medicine in favor of raising
her children.
Despite never really knowing her
grandparents—Winternitz was 5 when
her grandfather passed away in 1959,
and her grandmother had died 29 years
earlier in the prime of her life—she
feels that her grandparents exerted an
unconscious influence on her and her
relatives, one that has guided many of
them toward medicine. “Why did eight
of my cousins become physicians?”
Winternitz wondered. “We have a good
proportion of a medical school class.
That was my grandfather’s life’s work—
running a medical school.”
For much of Winternitz’s life her
father, Tom, talked little of her grandfather, as the two had broken ties many
years before. “Great men sometimes
are great men, but not great parents,”
she said. Winternitz believes that her
grandfather’s hot temperament led to the
schism between the two. Perhaps straining their relationship was the decision

made by Tom, the eldest son, not to
pursue a career in medicine. Instead
he followed the path of his maternal
grandfather, Thomas Watson, who with
Alexander Graham Bell invented and
developed the telephone. Tom Winternitz
worked as an electrical engineer with
Bell Laboratories for 40 years.
Sally Winternitz started medical
school at Rutgers in New Jersey and
after two years transferred to Tufts
in Boston, graduating in 1980. She
pursued internal medicine as her older
brother Charlie had done, which took
her to a residency at Case Western
Reserve University in Cleveland. But
Winternitz soon realized that psychiatry is her true calling. She completed
two years of internal medicine at Case
Western, focusing heavily on neurology
due to her plans to pursue psychiatry.
Then the break she was waiting for
appeared: she was offered a spot in the
general psychiatry training program
at Yale—a department founded by her
grandfather more than 50 years earlier.
Since completing the Yale program
in 1986, Winternitz has worked in
inpatient and outpatient psychiatry settings. She feels privileged to be allowed
to share in the very intimate struggles
raging within her patients and to be
trusted enough to lead them toward
solutions. “Spiritually, there isn’t a much
better place to be than being in the service of others, and that’s really important
to me,” she said.
Winternitz lives in Sequim, Wash.,
on the Olympic Peninsula, sheltered by
the Olympic Mountains on one side and
a view of the Strait of Juan de Fuca separating the United States and Canada on
the other. She runs a small psychiatry
practice in which she sees patients

alumni faces
Sally Winternitz carries on a family tradition
of entering medicine. A psychiatrist in the
Pacific Northwest, she is the granddaughter
of Milton Winternitz, legendary dean of the
School of Medicine.

m at t h e w b a r t o n

30

Medical School Reunion Weekend
June 4-6, 2010
• Alumni lectures:  Robert Klitzman, m.d. ’85 — When Doctors Become Patients
Jerrold M. Post, m.d. ’60 — When Illness Strikes the Leader
• The Legacy of Harvey Cushing at Yale: Past and Future Perspectives
• Tours of Medical Library, medical campus, West Campus,
and Smilow Cancer Hospital
• Dean Alpern’s State of the School address

two days per week, and also serves as
a psychiatric consultant at a local community health center. The balance of
Winternitz’s time is devoted to her husband, Matthew Barton, m.d., an anesthesiologist, and her two teenage children,
son Jay and daughter Babette.
Over the past few years, Winternitz
has done a lot of questioning to determine the role of her grandparents in
her life. She clearly recognizes the culture of medicine that they unknowingly
fostered within the family. However,
her revelations go deeper: “What’s
interesting to me in a synchronistic way
is that my life in some ways parallels
my grandmother’s, except that I get to
live mine and she died.” When Helen,
a much beloved wife and mother, died
from probable renal failure at the age
of 45, she left behind five children
between the ages of five and 14, and
a dark void within the family. “The
irony and sad part was that here was
this world-famous physician who had a
wife he couldn’t heal,” says Winternitz.
“Lucky me, I’m married to a physician,
I get to be a physician myself, and I get
to raise my kids.”
—Kara A. Nyberg

• Harvey Cushing Center Dedication and Open House
• Saturday evening Class Dinners

Familiar Faces
Weekend schedule and online registration:
medicine.yale.edu/alumni
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Do you have a colleague who is making
a difference in medicine or has followed
an unusual path since leaving Yale? We’d
like to hear about alumni of the School of
Medicine; Physician Associate Program;
and the medical school’s doctoral, fellowship, and residency programs. Drop us a
line at ymm@yale.edu or write to Faces,
Yale Medicine, 300 George Street, Suite
773, New Haven, CT 06511.

notes

Helen Smits
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Jennifer and Matthew Davids

1960s
Helen L. Smits, m.d. ’67, was
inducted into the Connecticut
Women’s Hall of Fame in October.
Smits, a retired physician-manager
whose most recent work has
been in Mozambique and other
countries in sub-Saharan Africa,
was honored for her work as an
international health care leader
and teacher. She currently serves
as a senior consultant to the Doris
Duke Foundation’s African Health
Initiative. She is the former director of the John Dempsey Hospital
at the University of Connecticut
Health Center in Farmington, and
is a former member of the board
of directors of the Hartford Stage.

1970s
Colleen Livingston, m.d., hs ’73,
fw ’75, was recognized as a
Distinguished Life Fellow by the
American Psychiatric Association
at the annual meeting in San
Francisco last year. Livingston
has a private practice in Canton,
NY. She has a special interest in
mood and anxiety disorders.

1980s
Howard S. Jaffe, m.d. ’82, is president of the Gilead Foundation
and a member of Gilead’s senior
management team. Gilead is a
nonprofit that seeks to improve
the health and well-being of
underserved communities around
the world through expanding
access to hiv and hepatitis B
education, outreach, prevention,
and health services. He has been
a member of the management
team since 1991, serving in such
roles as chief medical officer and
senior vice president for drug
development. Prior to joining

George Lui

Gilead, Jaffe was director of clinical research and cytokine project
team leader at Genentech.
From 2002 to 2004, he served
as research director at the Gordon
and Betty Moore Foundation.
Jaffe is a former faculty member
at the University of California,
San Francisco, and has served
as an attending physician in internal medicine at San Francisco
General Hospital.
Diane Louie, m.d. ’87, m.p.h.,
wrote to say that after several
years as an attending pathologist at Memorial Sloan-Kettering
Cancer Center, in New York, she
reinvented herself. She earned
a degree in Health Policy and
Management at Columbia and
moved from academic medicine
to the pharmaceutical industry.
After positions at Merck & Co.
and Roche, she now works at
Sanofi-Aventis, where she is a
regulatory liaison to the fda,
developing oncology drugs and
companion diagnostic tests. She
lives in Madison, N.J., with her
husband, Paul Rothenberg, m.d.,
ph.d., who works in the pharmaceutical industry as a clinical
pharmacologist.

2000s
Jennifer Davids, m.d. ’05, and
Matthew Davids, m.d. ’05,
announced the birth of their first
child, Emily Isabella, on August 20,
2009. “Emily couldn’t wait to see
everyone, so she decided to come
a month early. Mom, Dad, and
baby are all doing well.” Jennifer
is a general surgery resident at
Brigham and Women’s Hospital.
Matthew is a hematology/oncology fellow in Harvard’s combined
Dana-Farber Cancer Institute,
Brigham and Women’s Hospital,
and Massachusetts General

David Spar and Barbara Wexelman

Hospital program. They live in
Boston.
George Lui, m.d. ’02, was
recently appointed director of
adult congenital heart disease at
Montefiore Medical Center, and
assistant professor of medicine
and pediatrics at the Albert
Einstein College of Medicine in
the Bronx, N.Y. He also received
the Outstanding Research Award
in Pediatric Cardiology at the
American Heart Association’s
2009 Scientific Sessions.
Jordan M. Prutkin, m.d. ’02,
was married on December 5 to
Heather S. Camp, r.n., m.p.h., a
nurse with the Seattle branch of
a company that provides nursing
and medical staff to hospitals
and other organizations. Prutkin
is an assistant professor in the
medicine-cardiology department
at the University of Washington
School of Medicine in Seattle.
Michael Singer, m.d. ’02, ph.d. ’02,
has completed his work with
HealthHonors, a behavioral economics company that he cofounded in 2006. He is now at the
Novartis Institutes for Biomedical
Research, where he’s working on
early-stage drugs for ophthalmology. He lives in Newton, Mass.
with his wife, Baha, an optometrist, and their two children, Leili
and Samia.
Barbara A. Wexelman, m.d. ’08.
m.b.a. ’08, was married on
October 24 to David S. Spar, m.d.,
hs ’08, in Westhampton Beach,
N.Y. Wexelman is a second-year
resident in general surgery at
St. Luke’s-Roosevelt Hospital in
Manhattan. Spar is a second-year
fellow in pediatric cardiology at
New York-Presbyterian/Columbia
University Medical Center.
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in memoriam
Karel B. Absolon, m.d. ’52, ph.d.,
died of respiratory failure on
October 2 at his home in Rockville,
Md. He was 83. Born in Brno in
what is now the Czech Republic,
Absolon left in 1948 during
the Communist takeover of his
homeland. A heart surgeon, he
was chief of surgery at Washington Hospital Center and also
worked at the National Institutes
of Health. He retired from the
National Heart, Lung, and Blood
Institute in the mid-1980s. Absolon was a collector of history and
medical books and wrote a threevolume biography of Theodor
Billroth, the father of modern
gastrointestinal surgery.
Sophia Chamberlin Alway,

m.d. ’41, died on February 10,

2009, in Redmond, Wash. She
was 92. Alway completed her
residency in pediatrics at the
University of Minnesota, where
she met her husband, also a
pediatrician. The couple moved
to Portola Valley, Calif., in 1955
when her husband, Robert H.
Alway, m.d., became dean of
Stanford Medical School.
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Donald S. Baim, m.d. ’75, a
cardiologist and medical device
executive, died on November 6
in Natick, Mass., following surgery
for adrenal cancer. He was 60.
Baim, a former professor of medicine at Harvard, most recently
was chief medical o≤cer at
Boston Scientific Corp., a manufacturer of medical devices. Baim
established the interventional
cardiology program at Beth Israel
Deaconess Medical Center, which
specialized in teaching surgeons
to use such new devices as stents.
He also edited the standard medical textbook for using the devices,
now in its seventh edition.
Albert W. Diddle, m.d. ’36, died
on December 23 in West Knoxville,
Tenn. He was 100. Diddle completed his residency in obstetrics/
gynecology at the University of
Iowa. He served as a physician in
the U.S. Navy in the Pacific and
China during World War II. After
the war he trained in oncology at
Parkland Hospital in Dallas, Texas.

He moved to Knoxville in 1948,
where he was the first boardcertified ob/gyn. He was on the
planning committee for the
University of Tennessee Medical
Center there and was one of the
original researchers of birth control pills. He published more than
130 papers during his career.
Peter A. Duncan, m.d. ’41, died on
September 25 in Greenwich, Conn.
He was 93. Duncan served as a
captain in the U.S. Army during
World War II and practiced pediatrics in Rye, N.Y. In the late 1970s
he founded the Birth Defects Center of Westchester County Medical Center and New York Medical
College in Valhalla, N.Y. Duncan, a
pioneering researcher in pediatric
dysmorphology, wrote more than
150 research articles and abstracts.
John L. Howland, med ’61, died on
October 18 in Brunswick, Maine.
He was 73. Howland joined the
faculty of Bowdoin College in
1963 as an assistant professor of
biology and by 1971 had elevated
biochemistry into a separate
department. He served as chair
of the department several times
and retired in 2002. He was best
known for his research into the
causes of muscular dystrophy
and the cellular biochemistry of
genetic disorders.
Alan M. Levine, m.d. ’74, hs ’80,
founder and director of the Alvin
& Lois Lapidus Cancer Institute
for Sinai Hospital and Northwest
Hospital Center in Baltimore,
died on October 25 in Pikesville,
Md., of a heart attack. He was 61.
Levine was renowned in his field
as an expert on scoliosis. He was
editor-in-chief of the Journal of
American Academy of Orthopaedic Surgeons for eight years;
his published works included
Skeletal Trauma and Nonoperative
Musculoskeletal Care. From 1976
to 1978, he was a commissioned
officer with the U.S. Public Health
Service. Levine was director of
the orthopaedic rehabilitation
unit at Montebello State Hospital

from 1980 to 1986. From 1983 to
1998, he was chief of orthopaedic
oncology service and director
of the spinal injury clinic at the
University of Maryland Medical Center. In addition to his
professional success, Levine was
active in charitable works. One
of his hobbies was making teddy
bears to explain the procedure of
scoliosis surgery to children facing
it and reduce their fears.
John R. Lyddy, m.d., hs ’57, died
on October 3 at Bridgeport Hospital. He was 90. A graduate of the
College of the Holy Cross and nyu
College of Medicine, Lyddy completed his residency in ob/gyn at
Yale. He served as a naval officer
during World War II and the
Korean conflict. He practiced general medicine in Bridgeport in his
early years and then established
a private practice in Stratford. He
also served at Bridgeport Hospital
for many years, both as chair of
ob/gyn and chief of staff. Lyddy
was an accomplished carpenter
and avid golfer. He loved sports,
particularly the New York Mets.
Donald M. Mandelbaum, m.d.,
hs ’72, died of brain cancer on

October 15 in Hollywood, Fla.
He was 69. Mandelbaum received
his medical degree from New
York University in 1965. After internships in New York and service
in the U.S. Army, Mandelbaum
completed a three-year diagnostic radiology residency at Yale.
In 1972 he moved to Hollywood to
join a radiology practice.
Hoyt B. Miles, m.d. ’43, died on
October 20 in Reno, Nev. He was
91. Although he played piano and
flute in high school and won two
national orchestral contests, Miles
decided on medicine when he
observed that the local musicians
were poor and that the family
doctor had two cars. After his
graduation from medical school
he served as a doctor with the 3rd
Marine Division on Guam. He also
served in China with the Marines.
After World War II he resumed
surgical training and practiced
urology in Los Angeles. In 1958
he opened a practice in Reno.

Lawrence E. Shulman, ph.d. ’45,
m.d. ’49, died on October 10 at
his home in Washington, d.c.,

from complications of bladder
cancer. He was 90. Shulman
helped to found the Johns
Hopkins University medical
school’s rheumatology department and was founding director
of the National Institute of
Arthritis, Musculoskeletal, and
Skin Diseases. He joined the
staff of the National Institutes
of Health in 1976; in 1994 he
was named director emeritus of
the arthritis institute. Shulman
received numerous national
and international awards and
fellowships for his service to the
field of medicine, including the
infrequently given Gold Medal
of the American College of
Rheumatology.
Harris B. Shumacker Jr., m.d.,
hs ’38, died on November 12 in

Gladwyne, Pa. He was 101. A
graduate of the medical school
of Johns Hopkins University,
Shumacker was a pioneer in heart
surgery and author of more than
600 professional articles and
papers, eight books and monographs and chapters in about
40 textbooks. He was an expert
in such areas as frostbite and the
early development of the artificial
heart. He served as an officer
in the U.S. Army; as consultant
to the surgeon general, he was
instrumental in putting the first
monkey into space in 1949.
Alvin Somberg, m.d. ’47, died
on October 13 in Chicago. After
his graduation from the School
of Medicine, Somberg, a general
and family practitioner, served
in the U.S. Army in France and
spent most of his medical career
at Swedish Covenant Hospital
in Chicago.
send obituary notices to
Claire M. Bessinger, Yale Medicine,
300 George Street, Suite 773,
New Haven, CT 06511, or via e-mail
to claire.bessinger@yale.edu

end note
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Back to the (not medical) boards
On two nights in January, in a lecture hall in the Jane Ellen Hope Building, a dozen
students in medicine, public health, law, and the Physician Associate Program forgot their studies and took on new roles. For the third year in a row, the Yale Med
Players presented a night of one-act plays, this year adding the first act of Oscar
Wilde’s The Importance of Being Earnest.
The troupe started four years ago when then-first-year medical students
Abigail Baird and Scott Hunter, theater buffs in high school, rekindled their interest in theater and staged a reading of The Doctor Stories by Richard A. Selzer, m.d.,
hs ’61. A year later, with support from Thomas P. Duffy, m.d., professor of medicine (hematology), and director of the Humanities in Medicine program, the group
decided to perform Selzer’s plays.
Their production this year, “Lost in Transplantation,” deliberately
eschewed medical themes. “We felt that we wanted to try something different,
something really funny, so we picked comedies,” said Baird.

Medical student Ramy Goueli played Algernon
and Alexandra Sowa, a medical student from
nyu at Yale for a fellowship, played Lady Bracknell in Oscar Wilde’s The Importance of Being
Earnest. The YaleMed Players also performed the
comedies The Statue of Bolivar and The Philadelphia, and Class Action, a monologue.

j o hn c u r t i s

—John Curtis

